BRIEF-Sarepta Therapeutics Q2 non-GAAP loss per share $1.19 excluding items
July 19, 2016 at 16:18 PM EDT
* No revenue was recognized for three months ended June 30, 2016 and 2015
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.